Results 211 to 220 of about 76,206 (274)

Targeting Peptidergic Systems for Melanoma Treatment. [PDF]

Cancers (Basel)
Sánchez ML, Mehboob R, Coveñas R.
europepmc   +1 more source

Somatostatin-based therapies for external gastrointestinal fistulas: Updated meta-analysis of randomized clinical trials. [PDF]

World J Gastrointest Pharmacol Ther
Ribeiro Junior MAF, Fontenelle Vieira L, Thalib HI, Fouzaan Albeez S, Heba Fakruddin F, Mirza Zafar Baig A, Mohammed H, Nafeesa Hashim S, Rauf Khan AA, Dib Possiedi R.   +9 more
europepmc   +1 more source

Cost savings associated with the adoption of lower-dose everolimus in patients with advanced neuroendocrine tumors. [PDF]

ESMO Gastrointest Oncol
de Almeida GR, Riechelmann RP, Brito AB, Taboada RG, da Silva ALM, Weschenfelder RF, Etges APBS.   +6 more
europepmc   +1 more source

A cecal lesion hiding a secret: underwater endoscopic mucosal resection revealed an occult appendiceal neuroendocrine tumor. [PDF]

Endoscopy
Maresca R, Schepis T, Piccirilli G, Rozera T, Pecere S, Spada C, Barbaro F.   +6 more
europepmc   +1 more source

Expanding the clinical tumor phenotype of the EPAS1-asssociated tumor syndrome.

J Clin Endocrinol Metab
Cole Y, Howarth S, Javaid A, Tarpey P, Scoffings D, Maher ER, Godfrey AL, Pacak K, Zhuang Z, Alkaissi H, Casey RT.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Somatostatin-28, somatostatin-14 and somatostatin analogs: Effects on thermoregulation

Brain Research, 1981
Somatostatins, somatostatin-14, somatostatin-28, and desAA [D-Trp8]-somatostatin, with differential potencies, act in the brain to reverse chemical-induced hypothermia and to produce hyperthermia. Somatostatins are more potent and loger acting than prostaglandin E2 in producing hyperthermia.
Marvin Brown
exaly   +3 more sources